> It's complicated, yes, but simplifying somewhat the "US" does not subsidize pharma startups. This is utterly false. Agencies like NIH, BARDA, and NSF fund ea

> It's complicated, yes, but simplifying somewhat the "US" does not subsidize pharma startups. This is utterly false. Agencies like NIH, BARDA, and NSF fund early-stage biomedical R&D by providing SBIR/STTR grants to biotech and pharma startups. They also fund basic research and clinical trials as well as translational studies. There is the Orphan Drug Tax Credit and R&D Tax Credit. Also, access to NIH labs, etc. There is a whole plethora of funding. Moderna’s mRNA platform was heavily backed by NIH and BARDA even before COVID.